Technology Offerings

Innovative Oligopeptide Therapy Targets Steroidal Cancers

Proprietary decapeptide drugs developed for tumor therapy of steroidal cancers (breast/mamma, ovarial, endometrial, prostate) and malignant melanoma. Mono-therapy or combi-therapy with current drugs possible due to huge synergism. Resensitization of tamoxifen resistant tumors and therapy of triple-negative breast cancer.

Further Information: PDF

MBM ScienceBridge GmbH
Phone: (0551) 30724-151

Contact
Dr. Jens-Peter Horst

Comments (0)

Write a comment